abstract |
Novel tricyclic compounds having a TXA 2 -antagonizing activity represented by formul (I):n which strongly antagonize an action of thromboxane A 2 and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc. |